Kalaris Therapeutics KLRS
NASDAQ KLRS
$1.90 -0.09 (-4.52%)
As of: Oct 23, 2026 · 3:24 PM EDT

Kalaris Therapeutics (KLRS) Net Shares Issued and Repurchased (2021 - 2026)

Updated

Analysis

Kalaris Therapeutics (KLRS) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,130.49 Bn 1,099.07 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 635.65 Bn 555.51 Bn 17.30 Bn -966.00 Mn
3 AbbVie 505.44 Bn 478.55 Bn 12.70 Bn -9.00 Mn
4 Merck 358.27 Bn 312.65 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 291.57 Bn 255.56 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.15 Bn 238.84 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.41 Bn 192.81 Bn 7.24 Bn -
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.23 Bn 117.87 Bn 10.94 Bn -
10 Kalaris Therapeutics 45.21 Mn -48.29 Mn - 10,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10,000.00
Mar 31, 2026 74,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 -20,000.00
Dec 31, 2023 11,000.00
Dec 31, 2022 292,000.00
Sep 30, 2022 126.43 Mn
Dec 31, 2021 65,000.00
API Access

Kalaris Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=KLRS&period=max&api_key=YOUR_API_KEY